MARATTO

dataset · Figshare

Additional file 7 of SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis

2023Open accessUniversity of Douala

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Additional file 7.

Research topics

  • IL-33, ST2, and ILC Pathways
  • Inflammasome and immune disorders
  • Cytokine Signaling Pathways and Interactions

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.6084/m9.figshare.22623367

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.